Isis Pharmaceuticals (IONS) Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi

Ionis Pharmaceuticals - IONS emitenti grafik logotipi

Ushbu GURU.Markets narxlar grafigi Ionis Pharmaceuticals (IONS) kompaniyasining narxlar dinamikasini aks ettiradi, uning strategiyasi yuqori daromadni ta'minlash uchun farmatsevtika kompaniyalariga haq evaziga litsenziya huquqlarini berishga asoslangan. Joriy ko'rsatkich 4.82 hisoblanadi. Hozirgi vaqtda tadqiqot va ishlanmalar (R&D) markazlari yurak va miya patologiyalariga qarshi kurashish uchun inqilobiy terapiyalarni ishlab chiqmoqda. Xatarlar keng qamrovli ishlanmalar portfeli va bozor yetakchilari bilan strategik hamkorliklar orqali minimallashtirilgan.

Ionis Pharma (IONS): Uzoq muddatli qarzning kapitalga nisbati 04.07.2022dan 29.10.2026gacha

Ionis Pharmaceuticals kompaniyasining tahliliy kesimlari

- joriy narx va aksiyalarning prognoz qilingan qiymati:
Aksiya kursi Ionis Pharmaceuticals, Inc.|IONS - Maqsadli narxlar grafigi
- bozor kapitallashuvi tafsilotlari:
Bozor kapitallashuvi Ionis Pharmaceuticals|IONS - Korxona qiymati
- emitentning balans qiymati statistikasi:
Bitta aksiya hisobiga balans qiymati Ionis|IONS - Balans kapitallashuvi|Balans qiymatiga nisbatan bozor kapitallashuvi ionispharma.com|IONS - Kompaniyaning jami aktivlari
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Qarzning kapitalga nisbati Ionis Pharmaceuticals|IONS - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga nisbati ko'rsatkichi ionispharma.com|IONS - Kompaniyaning jamlangan qarzlari|Sof aktivlarga qarzlar Ionis Pharmaceuticals|IONS - Kompaniyaning uzoq muddatli qarzi|Qisqa muddatli qarz hajmi Ionis
Kompaniyaning jamlanma tahlili:Ionis Pharmaceuticals
Ionis Pharmaceuticals, Inc. original mahsuloti

Ionis Pharmaceuticals (IONS) kompaniyasining kredit sifatini baholash uchun tahlilchi uzoq muddatli moliyaviy leveraj koeffitsiyentidan foydalanadi, u qarz mablag'lariga bog'liqlik darajasini aniqlash uchun muddati bir yildan ortiq bo'lgan majburiyatlarni kapital bilan solishtiradi. Ushbu ko'rsatkichning barqarorligi RNA dori vositalarini diversifikatsiya qilish strategiyasi va sog'liqni saqlash gigantlari bilan hamkorlik tomonidan qo'llab-quvvatlanadi, bu esa qarz yukini minimallashtiradi va kompaniyaning moliyaviy avtonomiyasini tasdiqlaydi.

Raqobatdosh kompaniyalar tahlili

Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi TEM (Tempus)|Uzoq muddatli qarzning o'z kapitaliga nisbati Qiagen Group (QGEN)|Repligen Inc. - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|Uzoq muddatli qarzning kapitalga nisbati RNA (Avidity Biosciences)|Uzoq muddatli qarzning kapitalga nisbati crisprtx.com CRSP|GeneDx - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzdorlikning kapitalga nisbati Ultragenyx Pharmaceutical Inc. RARE|Beam Therapeutics Corp (BEAM) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Sarepta Corp (SRPT)|Uzoq muddatli qarzning o'z kapitaliga nisbati Twist Bioscience|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi TXG (10xgenomics.com)|Uzoq muddatli qarzning kapitalga nisbati NTLA|Uzoq muddatli qarzdorlikning kapitalga nisbati Stoke Therapeutics Inc|Uzoq muddatli qarzning o'z kapitaliga nisbati BioLife Corp BLFS|Uzoq muddatli qarzdorlikning kapitalga nisbati Wave Pharma (WVE)|MAZE: Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti SION (sionnatx.com)|Prime Medicine (PRME) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati TSHA (Taysha Gene Therapies Inc)|QURE (uniQure Corp) - Uzoq muddatli qarzning kapitalga nisbati|MGTX: Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati RGNX|Uzoq muddatli qarzning kapitalga nisbati solidbio.com (SLDB)|Uzoq muddatli qarzning o'z kapitaliga nisbati Ocugen OCGN|Uzoq muddatli qarzning kapitalga koeffitsiyenti PACB|BNTC - Uzoq muddatli qarzning o'z kapitaliga nisbati|Design Corp (DSGN) - Uzoq muddatli qarzning o'z kapitaliga nisbati|RCKT: Uzoq muddatli qarzning kapitalga nisbati|4dmoleculartherapeutics.com (FDMT) - Uzoq muddatli qarzning kapitalga nisbati|LXEO (Lexeo Therapeutics Inc.) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Korro Bio, Inc (KRRO)|Uzoq muddatli qarzning kapitalga nisbati EDIT|SLN - Uzoq muddatli majburiyatlarning kapitalga nisbati|ProQR Therapeutics - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati Codexis Inc CDXS|SGMO: Uzoq muddatli qarzning o'z kapitaliga nisbati|Nautilus Biotechnology - Uzoq muddatli kreditlarning kapitalga nisbati|MGX: Uzoq muddatli qarzning kapitalga nisbati|DTIL - Uzoq muddatli qarzdorlikning kapitalga nisbati|GBIO (Generation Bio Co) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati boundlessbio.com (BOLD)|Uzoq muddatli qarzning kapitalga nisbati XCUR|Uzoq muddatli qarzning kapitalga nisbati imunon.com (IMNN)|Uzoq muddatli qarzning o'z kapitaliga nisbati Phio Pharmaceuticals Corp. PHIO|Mustang Bio Inc - Uzoq muddatli qarzning o'z kapitaliga nisbati|RNAZ - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzdorlikning kapitalga nisbati Bionano Genomics, Inc. BNGO|APDN: Uzoq muddatli qarzning kapitalga nisbati|BLUE - Uzoq muddatli qarzdorlikning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati ImmunoPrecise Antibodies Ltd|Uzoq muddatli majburiyatlarning kapitalga nisbati Omega Therapeutics Corp OMGA|Uzoq muddatli qarzning o'z kapitaliga nisbati Singular Genomics Systems (OMIC)|regulusrx.com - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|Uzoq muddatli qarzning o'z kapitaliga nisbati Syros Pharmaceuticals, Inc. SYRS|Uzoq muddatli qarzdorlikning kapitalga nisbati Telesis Bio Inc. (TBIO)|TRACON - Uzoq muddatli qarzning kapitalga nisbati|UBX (Unity Biotechnology, Inc) - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi